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Abstract
Members of the Cell Stress Society International (CSSI), Patricija van Oosten-Hawle (University of Leeds, UK), Mehdi
Mollapour (SUNY Upstate Medical University, USA), Andrew Truman (University of North Carolina at Charlotte, USA)
organized a new virtual meeting format which took place on November 5–6, 2020. The goal of this congress was to provide
an international platform for scientists to exchange data and ideas among the Cell Stress and Chaperones community during the
Covid-19 pandemic. Here we will highlight the summary of the meeting and acknowledge those who were honored by the CSSI.
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Introduction
Research on chaperones and the stress response has continued
despite the unprecedented disruptions caused by the COVID
pandemic. This congress, held virtually in place of the usual
Alexandria-Old Town meeting, was attended by over 300
people and brought together diverse speakers from all over
the world. Topics of discussion were as varied as the stress
response itself and ranged from talks on the fundamental prop-
erties of molecular chaperones to the relationship between the
stress response and cancer. The program included 4 keynote
speakers (Linda Hendershot, Harm Kampinga, Chris
Prodromou, and Veena Prahlad) and 13 invited speakers.
Larry Hightower (CSSI Founding President) and the principal
organizers (Patricija van Oosten-Hawle, Andrew Truman, and
Mehdi Mollapour) opened the meeting and introduced Linda
Hendershot who gave the Susan Lee Lindquist Science
without Boundaries Lecture on “ER mediated maintenance
of cellular proteostasis”, Fig. 1.
The endoplasmic reticulum stress response
The fidelity of cell surfaces and secreted proteomes is depen-
dent not only on the correct maturation of these proteins but
also on the ability to detect and destroy proteins that fail to
reach their native state. To better understand how these quality
control decisions are executed in the endoplasmic reticulum,
Linda Hendershot (St. Jude Children’s Research Hospital,
USA) explained how her group developed the first in vivo
peptide screen to identify binding preferences for the Hsp70
cognate BiP and its co-chaperones that are effectors in these
processes. She revealed that sites for pro-folding chaperones
BiP and ERdj3 were frequent, dispersed throughout two cli-
ents, and consistent with previous in vitro peptide screens.
Conversely, pro-degradation co-chaperones Grp170, ERdj4,
and ERdj5, which had not been previously queried, recog-
nized a distinct type of sequence that was longer, rich in aro-
matic residues, and possessed a high aggregation potential.
Mutational analyses provided insights into sequence recogni-
tion characteristics for these pro-degradation chaperones,
which could be readily introduced or disrupted, and the con-
sequences for client fates determined. Her fascinating data
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revealed unanticipated diversity in recognition sequences for
chaperones, established a sequence-encoded interplay be-
tween protein folding, aggregation, and degradation, and
highlighted the ability of clients to co-evolve with chaperones
ensuring quality control.
Similar to other Hsp70s, BiP functions rely on their ability
to cycle between several functionally distinct conformations.
Anastasia Zhuravleva (University of Leeds, UK) exploited
solution NMR and other biophysical techniques to character-
ize the BiP chaperone cycle and elucidate how the BiP chap-
erone cycle is regulated post-translationally by AMPylation of
the BiP substrate-binding domain (SBD) and binding Ca2+ to
the BiP nucleotide-binding domain (NBD). Her results sug-
gest that local perturbations in the BiP SBD and NBD fine-
tune the pre-existing conformational ensemble, enabling grad-
ual fine-tuning of BiP chaperone activity. These tunable prop-
erties of the chaperone cycle for BiP and other Hsp70s poten-
tially provide new opportunities to develop allosteric modula-
tors of their chaperone activity (Wieteska et al. 2017).
Chaperones (both cytoplasmic and ER-localized) are criti-
cal in tumor progression and metastasis. Jeff Brodsky
(University of Pittsburgh) discussed the ability of cancer cells
Fig. 1 First Virtual International Congress on Cellular and Organismal
Stress Responses was held with great success on November 5–6, 2020,
with over 300 participants. We thank the senior members of CSSI for
creating and maintaining an inspiring and inclusive environment for new
and established researchers to thrive
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to withstand severe stress, and suggested that these cells might
have been re-wired to withstand these stresses. Expanding
upon this concept, his lab identified and used Hsp70 inhibitors
to identify cancer cells that are susceptible to proteotoxic
stress, and then determined the mechanisms that allow these
cells to become resistant to the inhibitors. He then summarized
published and new data on the role of the autophagy pathway
in mediating resistance.
Cellular protein quality control
Molecular chaperones are not solo players; their activity and
specificity are dictated by a large number of semi redundant
co-chaperone proteins. Keynote speaker Harm Kampinga
(UMCG, The Netherlands) discussed the peculiar features of
the Hsp70 co-chaperone DNAJB6, one of the 50 members of
the J-domain protein family. DNAJB6 has excellent proper-
ties and capacities to delay the amyloidogenesis of a variety of
disease-causing proteins, most particularly those with expand-
ed polyglutamine sequences (polyQ proteins). DNAJB6 ex-
pression levels are tightly associated with cellular vulnerabil-
ity to polyQ aggregation and toxicity and these expression
levels have been found to decline upon differentiation from
stem cells to neurons, consistent with the neuronal degenera-
tion to which these polyQ proteins lead. DNAJB6 does not
interact with polyQ monomers, but with (small) polyQ oligo-
mers when formed and next prevents their transition into
amyloid-like aggregates.
Steven Bergink (UMCG, The Netherlands) showed that
DNAJB6 is also involved in Nuclear Pore Complex (NPC)
biogenesis. Impairment of DNAJB6 results in the accumula-
tion of the so-called annulate lamella—not fully assembled
NPCs—in the cytosol. Moreover, DNAJB6 localizes to
NPC—assembly intermediates—during the interphase of the
cell cycle, and interacts with FG nucleoporins (FG-Nups). The
FG-rich domains of Nups form condensates in the cytosol that
progress into amyloids over time, a process that is attenuated
by DNAJB6. This activity is reminiscent of the reported anti-
amyloidogenic action DNAJB6 has on polyglutamine pro-
teins or amyloid-β42. Their data provide the first evidence
for a role of chaperones in NPC biogenesis and suggests that
DNAJB6 acts as a chaperone for unstructured NPC compo-
nents, preventing them from aggregating.
Co-chaperone proteins also play an important role in prion
propagation. [PSI+] prions are amyloids of Sup35, an essential
protein. Puzzlingly, [PSI+] affects viability only modestly de-
spite substantial depletion of Sup35 into insoluble prion ag-
gregates. Dan Masison (NIH, USA) revealed that [PSI+] is
however highly toxic to cells with a truncated version of
Hsp70 J-protein co-chaperone Sis1. He described a dual role
for Sis1 in promoting [PSI+] propagation and in keeping
Sup35 soluble enough for cells to grow normally. Thus, Sis1
is crucial for [PSI+] prions to maintain a balance between
depleting enough Sup35 to propagate stably and retaining
enough soluble Sup35 for normal growth, which provides an
explanation for persistence of otherwise lethal [PSI+] prions.
Bacteria represent a huge reservoir of unexplored J-domain
proteins (JDPs), the co-chaperones of HSP70/DnaK. By
studying the aquatic bacterium Shewanella oneidensis,
Olivier Genest (CNRS, Aix Marseille University) revealed
that AtcJ, a short JDP of 94 amino acids containing only a J-
domain and a C-terminal extremity of 21 amino acids, is re-
quired for growth at low temperature. AtcJ interacts through
its C-terminal extremity with AtcC, that itself interacts with
AtcB, two proteins also important for cold adaptation. Recent
results indicate that AtcB contacts the RNA polymerase, sug-
gesting that the Atc proteins could target DnaK to the RNA
polymerase (Maillot et al. 2019).
Kevin Morano (University of Texas, USA) presented new
work demonstrating that yeast cells defective in redox buffer-
ing exhibit chronic activation of a heat shock response.
Specifically, mutants in the cytosolic thioredoxin pathway,
but not the glutathione or mitochondrial thioredoxin systems,
activated the transcription factor Hsf1. UsingHSP-GFP fusion
proteins, the sequestrate Hsp42 but not the Hsp70/Hsp104
disaggregase machine was found to localize in the perinuclear
JUNQ compartment in stable foci. Thioredoxin mutants like-
wise accumulated the permanently misfolded model protein
CPY-GFP but were competent to refold heat-denatured firefly
luciferase, suggesting defects in substrate processing through
the ubiquitin-proteasome pathway. These findings reveal a
previously unknown and important link between redox ho-
meostasis and protein quality control.
Chaperone structure and function
Over the past several decades, substantial effort has gone into
probing the structure and mechanisms of the stress responses.
It was exciting to see that there is still room for fundamental
discoveries to be made in this area. In his keynote talk,
Chrisostomos Prodromou (University of Sussex, UK) present-
ed the cryo-EM structure of the human and yeast R2TP-TTT
complex (human: RUVBL1/2-RPAP3-PIH1D1-TELO2-
TTI1-TTI2)1. A subcomplex of human R2-TTT (RUVBL1/
2) was resolved at 3.4 Å for the R2 (RUVBL1/2) ring and 5 Å
for the TTT module. The structures reveal the binding of the
TTT complex to the R2 ring. There was evidence that the TP
(RPAP3-PIH1D1) component of the R2TP complex was pres-
ent through tethering, but was essentially not visible, due to
the flexible nature of its interaction. Studies using the
Kluveromyces maxianus TOR1 showed details of its interac-
tion with the R2TP-TTT complex and which domains were
critical for its recruitment (Pal et al. 2020).
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Recently, substantial progress has been made in determin-
ing direct interactors of Hsp90 (Weidenauer et al. 2017).
Adding to this wealth of knowledge, the laboratory of Brian
Freeman (UIUC) exploited a number of yeast Hsp90 variants
containing the non-natural amino acid p-benzoyl-l-
phenylalanine (Bpa), which also serves as a UV-triggered
crosslinker, to reveal a broad Hsp90 physical interactome
comprised of >1000 hits. Intriguingly, the use of the Bpa-
crosslinker identified two different classes of Hsp90
clients—a classic, stably Hsp90-associated one and a more
transient Hsp90-regulated class. Validation studies demon-
strate that the transient clients depend on Hsp90 in a variety
of cellular pathways including transcription, translation, and
genome organization.
Similarly, Jill Johnson (University of Idaho) described
identification of groups of yeast Hsp90 mutants that have
differing effects on Hsp90 interaction with Hsp70 or co chap-
erones. Mutations within the same group exhibited similar
effects on client activity. Surprisingly, one group of Hsp90
mutations had limited effects on activity of select clients, sug-
gesting they result in altered client specificity. Given the large
number of PTMs on chaperones, it is possible that some of
these mutants are at either sites of modification or in close
proximity (Backe et al. 2020; Nitika et al. 2020b).
Adrienne Edkins (Rhodes University, South Africa) de-
scribed the importance of chaperone interactions in the extra-
cellular matrix. Fibronectin (FN) is a client protein of Hsp90
that is an important component of the extracellular matrix
(ECM). Hsp90 interacts via its M-domain directly with N-
terminal proteolytic FN fragments, with the binding affinity
determined by the intrinsic stability of the FN fragments and
the presence of type I FN repeats. Exogenous extracellular
Hsp90 altered the size and orientation of individual FN fibers
and promoted the incorporation of soluble fibronectin into
ECM, consistent with the role of the FN N-terminus in FN
ECM assembly.
Chaperones have long been investigated as potential anti-
cancer therapeutic agents, although issues of patient toxicity
have remained problematic. Brian Blagg (Notre Dame
University, USA) presented preliminary studies that empha-
sized the development and evaluation of isoform-selective
inhibitors of the Hsp90α isoform. Through a structure-based
approach small molecules were developed that selectively
bound to the Hsp90β isoform in lieu of Hsp90α, which are
~95% identical in the N-terminal ATP-binding sites. A small
sub pocket was exposed in Hsp90β that allowed for the inclu-
sion of appendages that when incorporated significantly en-
hance affinity for Hsp90β, while presenting detrimental inter-
actions with Hsp90α. These new compounds were able to
induce the degradation of Hsp90β-dependent substrates in
various cell lines and manifested submicromolar EC50s
against select cancer cell lines. In addition, no induction of
Hsp90 levels was observed, indicating that the Hsp90β-
selective inhibitors overcome many of the detriments associ-
ated with the pan-Hsp90 inhibitors that were evaluated clini-
cally (Khandelwal et al. 2018).
Organismal and intercellular level stress
responses
Although mechanistic in vitro studies are critical for under-
standing basic properties of chaperones, it is essential to con-
sider how they are regulated not only at a cellular level but
also at an organismal level. Veena Prahlad (University of
Iowa) elegantly described neuronal control over the cellular
heat shock response in the nematode C. elegans. Organisms
function despite wide fluctuations in their environment
through the maintenance of homeostasis. In general, two dis-
tinct kinds of strategies are used by organisms to achieve
homeostasis. The first are servomechanisms, whereby error-
sensing negative feedback loops triggered by the perturbation
of some set-point, correct the performance of a system to
restore homeostasis. An alternate mechanism is through the
activation of anticipatory or cephalic mechanisms that are pre-
dictive and implemented prior to the actual perturbation of the
system (Prahlad 2020). Dr. Prahlad discussed work over the
last few years from her lab that provides evidence for the
existence of a cephalic mechanism of control over the heat
shock response. Her data showed that such cephalic control
is mediated by the release of the neuromodulator serotonin,
linking anxiety, experience, learning—aspects that are funda-
mental to cephalic processes—to cellular changes in transcrip-
tion and protein quality control. Finally, she discussed her
recent findings that serotonin acts through a signal transduc-
tion pathway conserved between C. elegans and mammalian
cells to enable the transcription factor HSF1 to alter chromatin
in soon-to-be fertilized germ cells by recruiting the histone
chaperone FACT, displacing histones, and initiating protec-
tive gene expression. Without serotonin release by maternal
neurons, FACT is not recruited by HSF1 in germ cells and
progeny of stressed C. elegans mothers fail to complete de-
velopment (Das et al. 2020). These studies are just beginning
to uncover how stress sensing bymaternal neurons, coupled to
HSF1-dependent transcription in the germline, could result in
the epigenetic remodeling of offspring (Das et al. 2020).
HSF1 is also critical in the transcriptional program required
for tumor survival. Tumors are stressful environments, and
various stress responses are activated in cancer cells and in
non-malignant cells of the tumor microenvironment to cope
with these stressful conditions. These pathways have been
classically shown to be activated in a cell-autonomous man-
ner; however, accumulating evidence over the past years sug-
gests that non-cell-autonomous activation of stress responses
plays important roles in tumor progression, metastasis, and
immune evasion. Ruth Scherz-Shouval (Weizmann Institute
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of Science, Israel) showed that heat shock factor 1 (HSF1) is
activated in response to inflammatory signals in stromal fibro-
blasts of the gut, and that its activation promotes ECM remod-
eling, leading to the development of colon cancer. Loss of
HSF1 abrogates ECM assembly by colon fibroblasts in cell
culture, prevents ECM remodeling in a mouse model of
inflammation-induced colon cancer, and significantly inhibits
progression to colon cancer. These findings highlight HSF1 as
a key mediator of the response to inflammation in the colon,
and highlight another facet of the many roles of stress re-
sponses in health and disease (Levi-Galibov et al. 2020).
The chaperone/co-chaperone system is also critical for a
robust immune response and cancer cell drug resistance
(Nitika et al. 2020a; Shevtsov et al. 2019a). Gabriele
Multhoff (Technical University ofMunich, Germany) showed
that the major stress-inducible Hsp70 (HSPA1A) is frequently
overexpressed in the cytosol of a large variety of different
tumor entities and presented on the plasma membrane in a
tumor-specific manner (Stangl et al. 2018). High cytosolic/
membrane Hsp70 levels are associated with therapy resistance
and unfavorable prognosis. Moreover, membrane Hsp70 pos-
itive tumor cells actively release Hsp70 in exosomes that serve
as a biomarker for the membrane Hsp70 status and reflect the
viable tumor mass in liquid biopsies (Gunther et al. 2015).
Highly aggressive, membrane Hsp70 positive tumor cells
can be recognized and killed by Hsp70 peptide TKD and IL-
2 (TKD/IL-2) stimulated NK cells in vitro and in vivo.
Therefore, patients with non-resectable, advanced NSCLC
(stage IIIa/b) were either treated with 4 cycles of ex vivo stim-
ulated NK cells or received best supportive care after radio-
chemotherapy in a randomized phase II clinical trial. The im-
proved clinical outcome of NSCLC patients after adoptive NK
cell transfer was clearly mediated by NK cells expressing
activatory (C-type lectin) NK cell receptors. Based on prom-
ising preclinical data and a pilot study (Kokowski et al. 2019;
Shevtsov et al. 2019b), future plans are to treat NSCLC pa-
tients with a combined regimen consisting of ex vivo TKD/IL-
2 activated NK cells and immune checkpoint inhibitors in an
upcoming clinical trial.
Finally, Antonio De Maio (UC San Diego) discussed
Coronavirus Disease 2019 (COVID-19) that is triggered by
infection by a new coronavirus, severe acute respiratory syn-
drome coronavirus 2 (SARS-CoV-2), with a rapid transmission
rate (Hightower and Santoro 2020), which has resulted in a
worldwide pandemic due to various factors, including propaga-
tion from asymptomatic infected individuals, speedy interna-
tional travel, and poor mitigation approaches adopted in some
regions. Although the mortality rate of COVID-19 is less than
prior coronavirus epidemics (Fauci et al. 2020), this disease has
been a tremendous burden to the world population and econo-
my. The clinical outcome from COVID-19 is modulated by
multiple factors, including the level of the infection, the genetic
background, gender and age of the patient, and non-genetic
factors, such as obesity, smoking, economic status, and envi-
ronmental conditions. SARS-CoV-2 cellular infection triggers
a corresponding activation of the innate immune system that is
initially beneficial, but if it is not properly controlled, results in
an overwhelming inflammatory response that is detrimental
long-term due to the development of innate immune dysfunc-
tion, defined as the inability to respond to subsequent stressors,
a condition exacerbated by metabolic exhaustion. Therefore,
early therapeutic interventions could be critical to ameliorating
the outcome from COVID-19. A potential intervention, partic-
ularly in conditions of low oxygen saturation levels, is hyper-
baric oxygen treatment, consisting of systemic exposure to
100% oxygen under increased atmospheric pressure (De
Maio and Hightower 2020; Kjellberg et al. 2020), which ap-
pears to be successful in limited clinical trials (Gorenstein et al.
2020; Thibodeaux et al. 2020).
Awards
The Executive Council of the CSSI has established The
Ferruccio Ritossa Early Career Award. The award was created
to celebrate the fiftieth anniversary of the discovery of the heat
shock response by the late Ferruccio Ritossa who made this
pioneering discovery early in his academic career. Len
Neckers (CSSI President) presented the 2020 Ritossa Early
Career Award to Dimitra Bourboulia (SUNY Upstate
Medical University, USA) for her contribution in deciphering
the function and regulation of extracellular Hsp90 in cancer.
The Executive Council of CSSI has also established the
Alfred Tissières Young Investigator Award, in honor and re-
membrance of Alfred Tissières, a pioneering investigator in
the heat shock and cellular stress response field. Larry
Hightower (CSSI Founding President) presented the 2020
Alfred Tissières Young Investigator Award to Maxim
Shevtsov (Technical University of Munich, Germany).
Finally, Larry Hightower presented service awards to the fol-
lowing new CSSI Fellows; Jeff Brodsky, Heath Ecroyd,
Adrienne Edkins, Brian Freeman, Pierre Goloubinoff,
Patricija van Oosten-Hawle, Jill Johnson, Kevin Morano,
Matthias Mayer, Dennis Thiele, Andrew Truman, and
Elizabeth Waters. The following were made new CSSI
Senior Fellows; Greg Blatch, Wilbert Boelens, Francesco
Cappello, Heather Durham, and Cassandra Tierney.
Concluding remarks
This first virtual meeting was a success, with many new par-
ticipants all over the world. The virtual nature and free-of-
charge registration provided an excellent opportunity to attend
the conference and so expanded the CSSI community. It was
exciting to see that 17 new members have joined the CSSI
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since the virtual meeting. Importantly, the conference was
attended by many undergraduate researchers with an interest
in molecular chaperones and cellular stress responses. CSSI
provided free complimentary membership to the society for 1
year to 5 undergraduate researchers who chose to participate
at the 2020 virtual conference.
Although virtual meetings can never fully replace in-
person meetings that facilitate the formation of new collabo-
rations and wonderful networking opportunities, the great suc-
cess of this virtual meeting suggests that a hybrid meeting may
the format of choice in the years to come.
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